661 related articles for article (PubMed ID: 19703377)
1. Effects of iron depletion on antimicrobial activities against planktonic and biofilm Pseudomonas aeruginosa.
Cai Y; Yu XH; Wang R; An MM; Liang BB
J Pharm Pharmacol; 2009 Sep; 61(9):1257-62. PubMed ID: 19703377
[TBL] [Abstract][Full Text] [Related]
2. Persister cells, the biofilm matrix and tolerance to metal cations in biofilm and planktonic Pseudomonas aeruginosa.
Harrison JJ; Turner RJ; Ceri H
Environ Microbiol; 2005 Jul; 7(7):981-94. PubMed ID: 15946294
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures.
Tré-Hardy M; Vanderbist F; Traore H; Devleeschouwer MJ
Int J Antimicrob Agents; 2008 Apr; 31(4):329-36. PubMed ID: 18280117
[TBL] [Abstract][Full Text] [Related]
4. In vitro effectiveness of the antibiotic lock technique (ALT) for the treatment of catheter-related infections by Pseudomonas aeruginosa and Klebsiella pneumoniae.
Lee MY; Ko KS; Song JH; Peck KR
J Antimicrob Chemother; 2007 Oct; 60(4):782-7. PubMed ID: 17681978
[TBL] [Abstract][Full Text] [Related]
5. Stationary biofilm growth normalizes mutation frequencies and mutant prevention concentrations in Pseudomonas aeruginosa from cystic fibrosis patients.
García-Castillo M; del Campo R; Baquero F; Morosini MI; Turrientes MC; Zamora J; Cantón R
Clin Microbiol Infect; 2011 May; 17(5):704-11. PubMed ID: 20673272
[TBL] [Abstract][Full Text] [Related]
6. Bismuth-thiol incorporation enhances biological activities of liposomal tobramycin against bacterial biofilm and quorum sensing molecules production by Pseudomonas aeruginosa.
Halwani M; Hebert S; Suntres ZE; Lafrenie RM; Azghani AO; Omri A
Int J Pharm; 2009 May; 373(1-2):141-6. PubMed ID: 19429299
[TBL] [Abstract][Full Text] [Related]
7. Bactericidal activity of various antibiotics against biofilm-producing Pseudomonas aeruginosa.
Abdi-Ali A; Mohammadi-Mehr M; Agha Alaei Y
Int J Antimicrob Agents; 2006 Mar; 27(3):196-200. PubMed ID: 16459057
[TBL] [Abstract][Full Text] [Related]
8. The assessment of the antibacterial and antifungal activities of aspirin, EDTA and aspirin-EDTA combination and their effectiveness as antibiofilm agents.
Al-Bakri AG; Othman G; Bustanji Y
J Appl Microbiol; 2009 Jul; 107(1):280-6. PubMed ID: 19302313
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of ceftazidime, ciprofloxacin, meropenem, minocycline, tobramycin and trimethoprim/sulfamethoxazole against planktonic and sessile Burkholderia cepacia complex bacteria.
Peeters E; Nelis HJ; Coenye T
J Antimicrob Chemother; 2009 Oct; 64(4):801-9. PubMed ID: 19633000
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
Hill D; Rose B; Pajkos A; Robinson M; Bye P; Bell S; Elkins M; Thompson B; Macleod C; Aaron SD; Harbour C
J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967
[TBL] [Abstract][Full Text] [Related]
11. Interaction between tobramycin and CSA-13 on clinical isolates of Pseudomonas aeruginosa in a model of young and mature biofilms.
Nagant C; Tré-Hardy M; El-Ouaaliti M; Savage P; Devleeschouwer M; Dehaye JP
Appl Microbiol Biotechnol; 2010 Sep; 88(1):251-63. PubMed ID: 20625718
[TBL] [Abstract][Full Text] [Related]
12. A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance.
Mah TF; Pitts B; Pellock B; Walker GC; Stewart PS; O'Toole GA
Nature; 2003 Nov; 426(6964):306-10. PubMed ID: 14628055
[TBL] [Abstract][Full Text] [Related]
13. The galactophilic lectin, LecA, contributes to biofilm development in Pseudomonas aeruginosa.
Diggle SP; Stacey RE; Dodd C; Cámara M; Williams P; Winzer K
Environ Microbiol; 2006 Jun; 8(6):1095-104. PubMed ID: 16689730
[TBL] [Abstract][Full Text] [Related]
14. Silver against Pseudomonas aeruginosa biofilms.
Bjarnsholt T; Kirketerp-Møller K; Kristiansen S; Phipps R; Nielsen AK; Jensen PØ; Høiby N; Givskov M
APMIS; 2007 Aug; 115(8):921-8. PubMed ID: 17696948
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial activity of fosfomycin and tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditions.
McCaughey G; McKevitt M; Elborn JS; Tunney MM
J Cyst Fibros; 2012 May; 11(3):163-72. PubMed ID: 22138067
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of ciprofloxacin, moxifloxacin, vancomycin and erythromycin against planktonic and biofilm forms of Corynebacterium urealyticum.
Soriano F; Huelves L; Naves P; Rodríguez-Cerrato V; del Prado G; Ruiz V; Ponte C
J Antimicrob Chemother; 2009 Feb; 63(2):353-6. PubMed ID: 19056748
[TBL] [Abstract][Full Text] [Related]
17. Discrepancy between viable counts and light output as viability measurements, following ciprofloxacin challenge of self-bioluminescent Pseudomonas aeruginosa biofilms.
Marques CN; Salisbury VC; Greenman J; Bowker KE; Nelson SM
J Antimicrob Chemother; 2005 Oct; 56(4):665-71. PubMed ID: 16105852
[TBL] [Abstract][Full Text] [Related]
18. Effect of oxygen limitation on the in vitro antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa grown planktonically and as biofilms.
Field TR; White A; Elborn JS; Tunney MM
Eur J Clin Microbiol Infect Dis; 2005 Oct; 24(10):677-87. PubMed ID: 16249934
[TBL] [Abstract][Full Text] [Related]
19. The role of quorum sensing system in antimicrobial induced ampC expression in Pseudomonas aeruginosa biofilm.
Zhao J; Jiang H; Cheng W; Wu J; Zhao J; Wang J; Dong L
J Basic Microbiol; 2015 May; 55(5):671-8. PubMed ID: 25112215
[TBL] [Abstract][Full Text] [Related]
20. Biofilm susceptibility to metal toxicity.
Harrison JJ; Ceri H; Stremick CA; Turner RJ
Environ Microbiol; 2004 Dec; 6(12):1220-7. PubMed ID: 15560820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
